Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations

POZEN

Status and phase: Completed; Phase 1

Conditions: Arthritis

Treatments: Drug: Naproxen; Drug: PN400

Study type: Interventional

Funder types: Industry

Identifiers

NCT00692055

PN400-105

Details and patient eligibility

About

We will evaluate the bioavailability of naproxen 375 mg in two formulations

Enrollment: 30 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male or non-pregnant female subjects between 18-55 years as well as other standard inclusion criteria for a study of this nature

Exclusion criteria

• Standard exclusion criteria for a study of this nature

Trial design

Primary purpose: Basic Science

Allocation: Randomized

Interventional model: Crossover Assignment

Masking: None (Open label)

---

30 participants in 2 patient groups

1

Experimental group

Description:

PN400

Treatment:

Drug: PN400

2

Active Comparator group

Description:

naproxen 375 mg

Treatment:

Drug: Naproxen